We analyzed PD-L1 in hepatoblastoma cell lines and found that our previously investigated CSC population of CD34+/highOV-6highCD90+csVimentin+ cells express PD-L1, whereas non-CSC tumor cells were negative for PD-L1. The gene discussed is CD34; the disease is neoplasm.